DexCom, Inc. (LON:0A4M)
London · Delayed Price · Currency is GBP · Price in USD 79.31
-2.38 (-2.91%)
At close: Jun 23, 2025
Theseus Pharmaceuticals Market Cap
DexCom has a market cap or net worth of 23.47 billion as of August 1, 2025. Its market cap has decreased by -33.03% in one year.
Market Cap
23.47B
Enterprise Value
23.21B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$79.31
Market Cap Chart
Since April 14, 2005, DexCom's market cap has increased from 157.23M to 23.47B, an increase of 14,827.61%. That is a compound annual growth rate of 27.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 23.47B | -3.27% |
| Dec 31, 2024 | 24.26B | -35.54% |
| Dec 29, 2023 | 37.64B | 3.69% |
| Dec 30, 2022 | 36.30B | -5.55% |
| Dec 31, 2021 | 38.43B | 47.80% |
| Dec 31, 2020 | 26.00B | 72.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.60B |
| HSBC Holdings | 160.06B |
| Shell | 159.31B |
| Unilever | 109.82B |
| Rolls-Royce Holdings | 89.38B |
| British American Tobacco p.l.c. | 88.30B |
| Rio Tinto Group | 76.62B |
| RELX PLC | 72.00B |